Hospitals

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection

REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS.REC-3964 represents a novel, non-antibiotic approach with a unique mechanism...

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury

Initiative will test Grifols ocular surface immunoglobulin (OSIG) eye drops to evaluate their nonclinical efficacy in neutralizing symptoms from exposure...

Pharmacovigilance and Drug Safety Software Market to grow by USD 69.1 Million from 2024-2028, driven by rising adverse drug event rates, with AI driving market transformation – Technavio

Exploratory Mindset Drives Insights at HLTH 2024: Black Book Poll Reveals Attendees Prioritizing Learning Over Immediate Investments

Survey reveals attendees are postponing AI and IT initiatives as budget constraints shift focus to internal system challenges, with unproven...

Global Health Exhibition Opens its Doors Tomorrow to Record-Breaking 100,000+ Attendees to World’s Premier Healthcare Transformation Event

Kingdom of Saudi Arabia opens the Global Health Exhibition (21-23 October 2024) tomorrow, a major international healthcare event with 100,000+...

GE HealthCare, the GE HealthCare Foundation, and the Charles Antetokounmpo Family Foundation commit $1M to improve Milwaukee health outcomes

The “Powering Milwaukee Forward” initiative will fund 10 Milwaukee organizations to increase access to basic needs and maternal healthcare in...

error: Content is protected !!